SG10201508420VA - Improved harvest operations for recombinant proteins - Google Patents

Improved harvest operations for recombinant proteins

Info

Publication number
SG10201508420VA
SG10201508420VA SG10201508420VA SG10201508420VA SG10201508420VA SG 10201508420V A SG10201508420V A SG 10201508420VA SG 10201508420V A SG10201508420V A SG 10201508420VA SG 10201508420V A SG10201508420V A SG 10201508420VA SG 10201508420V A SG10201508420V A SG 10201508420VA
Authority
SG
Singapore
Prior art keywords
recombinant proteins
harvest operations
improved harvest
improved
operations
Prior art date
Application number
SG10201508420VA
Inventor
Michael W Laird
John Richard St
Jane V Gunson
Kim Kaleas
Deepa Nadarajah
Rachel Adams
Bradley R Snedecor
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG10201508420VA publication Critical patent/SG10201508420VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/42Means for regulation, monitoring, measurement or control, e.g. flow regulation of agitation speed
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Sustainable Development (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201508420VA 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins SG10201508420VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261616297P 2012-03-27 2012-03-27

Publications (1)

Publication Number Publication Date
SG10201508420VA true SG10201508420VA (en) 2015-11-27

Family

ID=48040433

Family Applications (4)

Application Number Title Priority Date Filing Date
SG10202007206WA SG10202007206WA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10201912877SA SG10201912877SA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG11201406112TA SG11201406112TA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10201508420VA SG10201508420VA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins

Family Applications Before (3)

Application Number Title Priority Date Filing Date
SG10202007206WA SG10202007206WA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG10201912877SA SG10201912877SA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins
SG11201406112TA SG11201406112TA (en) 2012-03-27 2013-03-14 Improved harvest operations for recombinant proteins

Country Status (21)

Country Link
US (8) US20140080180A1 (en)
EP (1) EP2831261B1 (en)
JP (4) JP6225162B2 (en)
KR (2) KR102096678B1 (en)
CN (2) CN104350156B (en)
AR (2) AR090340A1 (en)
AU (3) AU2013240280A1 (en)
BR (1) BR112014023176B1 (en)
CA (2) CA2866753C (en)
ES (1) ES2654424T3 (en)
HK (1) HK1207120A1 (en)
HR (1) HRP20171966T1 (en)
IL (1) IL234377B (en)
MX (3) MX365947B (en)
MY (1) MY171729A (en)
PL (1) PL2831261T3 (en)
RU (2) RU2636353C2 (en)
SG (4) SG10202007206WA (en)
SI (1) SI2831261T1 (en)
WO (1) WO2013148249A1 (en)
ZA (1) ZA201406434B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109496237A (en) 2016-06-10 2019-03-19 隆扎有限公司 Method for stabilizing protein
WO2018085769A1 (en) * 2016-11-07 2018-05-11 Seattle Genetics, Inc. Distribution of engineered-cysteine caps
WO2019191133A1 (en) * 2018-03-27 2019-10-03 Bristol-Myers Squibb Company Real-time monitoring of protein concentration using ultraviolet signal
CN109725088B (en) * 2019-03-16 2021-05-18 丁立平 Gas chromatography-mass spectrometry combined method for measuring 2-naphthoic acid and derivatives thereof in bean sprouts
CN110305903B (en) * 2019-07-31 2021-10-01 江苏璟泽生物医药有限公司 Recombinant human follicle stimulating hormone and preparation method thereof
CN113155776A (en) * 2021-04-29 2021-07-23 华东交通大学 Prediction method for optimal harvest time of oranges
FR3146146A1 (en) 2023-02-24 2024-08-30 Bgene Genetics Production of 1-4-dihydroxy-2-naphthoic acid by Escherichia coli

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2036891B (en) 1978-12-05 1983-05-05 Windsor Smith C Change speed gear
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
JPS6147500A (en) 1984-08-15 1986-03-07 Res Dev Corp Of Japan Chimera monoclonal antibody and its preparation
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (en) 1984-12-04 1986-06-21 Teijin Ltd Expression of hybrid antibody gene
WO1987002671A1 (en) 1985-11-01 1987-05-07 International Genetic Engineering, Inc. Modular assembly of antibody genes, antibodies prepared thereby and use
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
EP0420937B1 (en) 1988-06-21 1994-11-09 Genentech, Inc. Therapeutic compositions for the treatment of myocardial infarction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE122006000006I2 (en) 1991-08-14 2011-06-16 Genentech Inc Altered immunoglobulins for specific FC epsilon receptors
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
ATE149570T1 (en) 1992-08-17 1997-03-15 Genentech Inc BISPECIFIC IMMUNOADHESINS
ES2112431T3 (en) 1992-08-21 1998-04-01 Genentech Inc PROCEDURE FOR THE TREATMENT OF AN LFA-1 MEDIATED DISORDER.
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
DE69405251T2 (en) 1993-12-10 1998-02-05 Genentech Inc METHODS FOR DIAGNOSIS OF ALLERGY AND TESTING ANTI-ALLERGIC THERAPEUTICS
DE69501817T2 (en) 1994-01-18 1998-09-10 Genentech Inc METHOD FOR TREATING PARASITAL INFECTIONS USING IGE ANTAGONISTS
JP3780315B2 (en) 1994-03-03 2006-05-31 ジェネンテク・インコーポレイテッド Anti-IL-8 monoclonal antibody for the treatment of inflammatory diseases
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
WO1996040210A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
WO1997026912A2 (en) 1996-01-23 1997-07-31 Genentech, Inc. Anti-cd18 antibodies for use against stroke
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
WO1998023761A1 (en) 1996-11-27 1998-06-04 Genentech, Inc. HUMANIZED ANTI-CD11a ANTIBODIES
DE122007000021I1 (en) 1997-04-07 2007-05-24 Genentech Inc Anti-vefg Antibodies
DE69838249T3 (en) 1997-05-15 2012-01-19 Genentech, Inc. ANTI-APO-2 ANTIBODIES
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
NZ518477A (en) 1999-10-29 2004-10-29 Genentech Inc Isolated anti-prostate stem cell antigen (PSCA) antibodies that internalise upon binding to PSCA on a mammalian cell, including a PSCA-expressing tumour cell, in vivo
US6946271B2 (en) * 2000-09-20 2005-09-20 Degussa Ag Nucleotide sequences which code for the menE gene
US6979556B2 (en) 2000-12-14 2005-12-27 Genentech, Inc. Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
BRPI0316779B1 (en) 2002-12-16 2020-04-28 Genentech Inc humanized antibody that binds human cd20, composition, manufactured article, apoptosis induction method, cd20 positive cancer treatment method, autoimmune disease treatment methods, isolated nucleic acids, expression vectors, host cells, method for producing a humanized 2h7 antibody, isolated polypeptide, liquid formulation, method of treating rheumatoid arthritis (ra) and humanized cd20 binding antibodies
JP4579158B2 (en) * 2003-03-26 2010-11-10 明治乳業株式会社 Method for stabilizing 1,4-dihydroxy-2-naphthoic acid
WO2005017162A2 (en) * 2003-08-13 2005-02-24 Sandoz Ag Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides
AU2005212237B2 (en) * 2004-02-04 2009-06-11 Merck Sharp & Dohme Llc Process for large scale production of plasmid DNA by E. coli fermentation
US7361764B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
CN101115832A (en) * 2004-11-26 2008-01-30 协和发酵工业株式会社 Industrially useful microorganism
ES2536852T3 (en) * 2006-05-05 2015-05-28 Gangagen, Inc. Phage-derived antimicrobial activities
JP5305615B2 (en) * 2006-06-05 2013-10-02 株式会社Adeka Method for producing menaquinone using gene groups of proteins involved in a novel biosynthetic pathway of menaquinone
ZA200900229B (en) * 2006-07-14 2010-04-28 Genentech Inc Refolding of recombinant proteins
DE17196350T1 (en) * 2007-07-09 2018-12-27 Genentech, Inc. PREVENTING DISULFIDE BINDING REDUCTION DURING THE RECOMBINANT PREPARATION OF POLYPEPTIDES
CN101665798B (en) * 2008-09-06 2012-11-21 浙江我武生物科技股份有限公司 Method for preparing recombinant human serum albumin and interferon alpha fusion protein
CN101503470A (en) * 2008-09-27 2009-08-12 上海交通大学 RhDSL recombinant protein and preparation thereof
JP2010088387A (en) * 2008-10-10 2010-04-22 Waseda Univ Promoter inducing and expressing target protein in actinomycetes

Also Published As

Publication number Publication date
MY171729A (en) 2019-10-25
CN104350156A (en) 2015-02-11
HRP20171966T1 (en) 2018-02-09
US20240158825A1 (en) 2024-05-16
US9765379B2 (en) 2017-09-19
AU2017202484A1 (en) 2017-05-04
ES2654424T3 (en) 2018-02-13
MX2019007032A (en) 2019-08-16
RU2636353C2 (en) 2017-11-22
US20200199639A1 (en) 2020-06-25
ZA201406434B (en) 2017-08-30
SG10202007206WA (en) 2020-08-28
RU2017139267A (en) 2019-02-12
SG10201912877SA (en) 2020-02-27
WO2013148249A1 (en) 2013-10-03
BR112014023176B1 (en) 2021-09-28
PL2831261T3 (en) 2018-04-30
US20210171997A1 (en) 2021-06-10
BR112014023176A2 (en) 2017-06-20
US20140080180A1 (en) 2014-03-20
CA3086730A1 (en) 2013-10-03
AR116615A2 (en) 2021-05-26
AU2017202484B2 (en) 2019-06-13
MX2018007677A (en) 2020-11-12
KR102096678B1 (en) 2020-04-02
US20150225760A1 (en) 2015-08-13
JP2019141049A (en) 2019-08-29
AU2019226192A1 (en) 2019-09-26
KR20140148392A (en) 2014-12-31
CA2866753C (en) 2020-09-22
HK1207120A1 (en) 2016-01-22
IL234377B (en) 2021-01-31
JP6225162B2 (en) 2017-11-01
SI2831261T1 (en) 2018-01-31
US20180291411A1 (en) 2018-10-11
CN104350156B (en) 2019-04-02
KR20200037425A (en) 2020-04-08
AU2013240280A1 (en) 2014-10-16
CA2866753A1 (en) 2013-10-03
EP2831261A1 (en) 2015-02-04
EP2831261B1 (en) 2017-10-18
US20160130624A1 (en) 2016-05-12
JP2018046825A (en) 2018-03-29
JP2015512259A (en) 2015-04-27
SG11201406112TA (en) 2014-10-30
MX365947B (en) 2019-06-19
MX2014011558A (en) 2014-11-14
US20230069966A1 (en) 2023-03-09
AR090340A1 (en) 2014-11-05
CN109880867A (en) 2019-06-14
RU2014137554A (en) 2016-05-20
JP2020202849A (en) 2020-12-24

Similar Documents

Publication Publication Date Title
HRP20190454T1 (en) Recombinant factor viii proteins
HRP20190025T1 (en) Recombinant bacterial host cell for protein expression
EP2929045A4 (en) Protein expression enhancing polypeptides
SG11201400432VA (en) Polypeptide vaccine
HK1207120A1 (en) Improved harvest operations for recombinant proteins
HK1205524A1 (en) Engineered conformationally-stabilized proteins
HK1207259A1 (en) Novel protein material
HK1204948A1 (en) Radiation-sterilization-resistant protein composition
SG10201507721SA (en) CHO-GMT Recombinant Protein Expression
GB201304973D0 (en) Recombinant protein
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB201223114D0 (en) Novel peptide
HK1207258A1 (en) Novel protein material
HK1201752A1 (en) Alternaria peptides
GB201213672D0 (en) Protein
HK1211952A1 (en) Recombinant protein
GB201210286D0 (en) Recombinant polypeptide
GB201215901D0 (en) Protein modification
GB201112985D0 (en) Polypeptide
GB201112849D0 (en) Polypeptide
GB201106130D0 (en) Polypeptide